Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dolby Laboratories, Inc. (DLB) vs Equinor ASA (EQNR) Price & Performance

Dolby Laboratories, Inc.Trade
Equinor ASATrade

Price performance (Past 24H)

Key statistics

Dolby Laboratories, Inc. vs Equinor ASA — how do they compare? Dolby Laboratories, Inc. trades at $58.45 (market cap $5.47B), while Equinor ASA trades at $42.72 (market cap $100.03B). The key difference: Equinor ASA is far larger — about 18.3× Dolby Laboratories, Inc.'s market cap, and Equinor ASA pays the higher dividend (3.75%). Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Equinor ASA for 59 Days on average.

DLBEQNR
Market Cap
$5.47B$100.03B
Volume
691,0164,457,638
Sector
TechnologyEnergy
52-Week High
$70.09$45.75
52-Week Low
$48.51$22.41
Typical Hold Time
98 Days59 Days
Enterprise Value
$4.84B$108.72B
Dividend Yield
2.47%3.75%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dolby Laboratories, Inc.

Dolby Laboratories (DLB) trades at $58.35, down 0.19% with bearish technical signals despite strong profitability margins. The company maintains robust fundamentals with 87.61% gross margins and consistent earnings beats, though revenue has plateaued around $1.3B. Recent leadership transition to Marc Whitten and expanded Meta partnership for Dolby Atmos/Vision represent key developments. Technical indicators show resistance at $59 with support at $58.

DLB offers stable cash flow generation and dividend income but faces growth challenges with flat revenue. Analyst consensus targets $90.33 (55% upside) with 47% buy ratings, though near-term execution risks and licensing volatility warrant caution. The stock presents value for income investors but requires revenue acceleration for significant appreciation.

Equinor ASA

Equinor (EQNR) trades at $42.93, down 0.19% on the day, with technical indicators showing a bearish trend despite recent earnings beats. The stock presents compelling value with a P/E of 11.28 and EV/EBITDA of 2.35, well below industry averages. Recent developments include expansion in LNG operations and carbon capture projects, while maintaining strong operational cash flow of $20B. The company continues shareholder returns through dividends and buybacks.

EQNR offers significant upside potential with a consensus price target of $70.50 representing 64% upside, supported by improving earnings outlook and strategic LNG expansion. Key risks include volatile energy prices and execution challenges in new projects. Analyst sentiment is mixed with 30% buy ratings, but recent Zacks upgrades to Strong Buy highlight growing optimism about earnings recovery through 2026.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DLB

No sentiment data available yet.

EQNR
53% Buy47% Sell
Avg holding period · 59 Days

Top news

Latest headlines on both assets

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Read more on DLB →

About Equinor ASA

Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.

Read more on EQNR →